World’s First Cannabis Validation Testing Program Hits the Market -- CFN Media


SEATTLE, Jan. 22, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- CFN Media Group (“CFN Media”), the leading agency and financial media network dedicated to the North American cannabis industry, announces publication of an article discussing BLOCKStrain Technology Corp. (TSX-V: DNAX) (OTC: BKKSF), and how the company’s partnership with WeedMD Inc. created the world’s first cannabis validation testing program.

The cannabis industry is expanding at a breakneck pace across North America and around the world. While the industry is heavily regulated, the rapid growth rates have led some companies to cut corners and favor quantity over quality. Contaminated and mislabeled products have become commonplace as regulators struggle to find ways to ensure product safety and efficacy without making costs so high that the black market returns.

BLOCKStrain Technology Corp. recognized these issues several years ago and began developing an innovative blockchain-powered solution. Unlike conventional databases, blockchain technology makes it easy to build highly-secure, highly-scalable, and immutable records that support billions of data points—whether they’re transactions, genetics, or tests.

Why Validation is Important

The cannabis industry is projected to exceed $146 billion by 2025, according to Grand View Research, driven by the legalization of medical and adult-use cannabis in North America and around the world. Despite the rapid growth, cannabis companies face several challenges as they ramp up production to meet consumer demand, consumers have trouble understanding what they’re buying, and regulators are struggling to keep pace.

For example, many cultivators and dispensaries have been forced to repurpose existing software solutions to comply with seed-to-sale regulations. Governments often require cultivators to submit data on government portals or even spreadsheets. These approaches take a lot of time and are prone to data loss, data theft, and a host of other problems, while they’re also difficult to search and understand for regulators.

There’s also no way for consumers to access reliable information about the products that they purchase—they must rely on brands that have only been around for a year or two. One recent study found that 35 percent of more than 80 strains tested had genetics that didn’t match the strain that was being sold. Consumers were buying Sativa strains that were advertised as Indica and Indica strains being advertised as Sativa.

BLOCKStrain & WeedMD Launch

BLOCKStrain and WeedMD recently announced a first-of-its-kind cannabis strain validation registration program. After collecting and registering DNA at its Ontario facility, WeedMD became the first licensed producer in the world to incorporate cannabis strain authenticity and tracking platform into its sales program. The information is now available in BLOCKStrain’s Master Genome Strain Registration and Clone Strain Registration database.

Please Click here to see a video on BLOCKStrain & WeedMD's Launch of the Industry's First Cannabis Validation Program. 

“For years, consumers have been purchasing cannabis products with very little information on what exactly is being purchased,” said Robert Galarza, CEO of BLOCKStrain, in a recent press release announcing the landmark development. “[Now they can] trace strain origin and their CBD/THC content, along with all other pertinent information … Producers can [also] guarantee their strains and provide customers with product assuredness.”

BLOCKStrain scientists gather all information from the plant genome, including molecular and chemical makeup, and store the information in an immutable blockchain database. With its open architecture, consumers, licensed producers, regulators, and other parties can easily use the database as a valuable reference. Quick response (QR) barcodes specific to each plant batch will show how it was cloned and cultivated along with its cannabinoid content.

Looking Ahead

BLOCKStrain Technology Corp. (TSX-V: DNAX) (OTC: BKKSF) plans to roll out this program to a growing number of licensed producers, cultivators, dispensaries, and other cannabis operations around the world. With a proof of concept live and in action, the company could have a much easier time convincing other parties to adopt the technology. The goal is to help deliver transparency to growers, retailers, regulators and consumers worldwide.

For more information, visit the company’s website or download their investor presentation.

Please follow the link to read the full article: https://www.cannabisfn.com/worlds-first-cannabis-validation-testing-program-hits-the-market/

About CFN Media

CFN Media (CannabisFN) is the leading agency and financial media network dedicated to the global cannabis industry, helps companies operating in the space attract investors, capital, and publicity. Since 2013, private and public cannabis companies in the US and Canada have relied on CFN Media to grow and succeed.

Learn how to become a CFN Media client company, brand or entrepreneur: http://www.cannabisfn.com/featuredcompany

Download the CFN Media iOS mobile app to access the world of cannabis from the palm of your hand: https://itunes.apple.com/us/app/cannabisfn/id988009247?ls=1&mt=8

Or visit our homepage and enter your mobile number under the Apple App Store logo to receive a download link text on your iPhone: http://www.cannabisfn.com

Disclaimer

CannabisFN.com is not an independent financial investment advisor or broker-dealer. You should always consult with your own independent legal, tax, and/or investment professionals before making any investment decisions. The information provided on http://www.cannabisfn.com (the ‘Site’) is either original financial news or paid advertisements drafted by our in-house team or provided by an affiliate. CannabisFN.com, a financial news media and marketing firm enters into media buys or service agreements with the companies that are the subject of the articles posted on the Site or other editorials for advertising such companies.  We are not an independent news media provider. We make no warranty or representation about the information including its completeness, accuracy, truthfulness or reliability and we disclaim, expressly and implicitly, all warranties of any kind, including whether the Information is complete, accurate, truthful, or reliable. As such, your use of the information is at your own risk. Nor do we undertake any obligation to update the items posted. CannabisFN.com received compensation for producing and presenting high quality and sophisticated content on CannabisFN.com along with financial and corporate news.  

The above article is sponsored content. Emerging Growth LLC, which owns CannabisFN.com and CFN Media, has been hired to create awareness. Please follow the link below to view our full disclosure outlining our compensation: http://www.cannabisfn.com/legal-disclaimer/

Frank Lane
206-369-7050
Flane@cannabisfn.com